Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-009940
Filing Date
2016-11-10
Accepted
2016-11-10 16:17:40
Documents
58
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vygr-20160930x10q.htm 10-Q 1473480
2 EX-31.1 vygr-20160930ex3113a38bd.htm EX-31.1 19763
3 EX-31.2 vygr-20160930ex312d3f9b4.htm EX-31.2 19762
4 EX-32.1 vygr-20160930ex3216e497a.htm EX-32.1 15409
5 GRAPHIC vygr20160930x10q001.jpg GRAPHIC 71955
  Complete submission text file 0001558370-16-009940.txt   6035481

Data Files

Seq Description Document Type Size
6 EX-101.INS vygr-20160930.xml EX-101.INS 1265643
7 EX-101.SCH vygr-20160930.xsd EX-101.SCH 44004
8 EX-101.CAL vygr-20160930_cal.xml EX-101.CAL 50148
9 EX-101.DEF vygr-20160930_def.xml EX-101.DEF 175036
10 EX-101.LAB vygr-20160930_lab.xml EX-101.LAB 382166
11 EX-101.PRE vygr-20160930_pre.xml EX-101.PRE 306221
Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37625 | Film No.: 161988271
SIC: 2836 Biological Products, (No Diagnostic Substances)